That's an easy target, I agree. I'm not too worried with its PPS as the board already authorized a $3 billion share buyback in February. This thing has a lot more room to go up compared to its largest rival EXPEDIA which is up 45% YTD. Priceline should be trading at a higher rate due to its subsidiary companies and international expansions. Seeing this up another 20-25% by year end to be its reasonable target. GLTYA!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.